Special tumours of the head and neck

Current Diagnostic Pathology

Volumn 9, Issue 6, 2003, Pages 366-383

  Perez Ordonez, B ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Adenocarcinoma; Endolymphatic sac; Middle ear adenoma; Nasal cavity; Olfactory neuroblastoma; Schneiderian papilloma; Sinonasal haemangiopericytoma; Sinonasal tract

Indexed keywords

ADENOCARCINOMA; CANCER GRADING; CLINICAL FEATURE; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; ENDOLYMPHATIC SAC; ESTHESIONEUROBLASTOMA; HEMANGIOFIBROMA; HEMANGIOPERICYTOMA; HISTOPATHOLOGY; HUMAN; MIDDLE EAR; MITOSIS INDEX; NASOPHARYNX CARCINOMA; NEUROENDOCRINE TUMOR; NOSE MUCOSA; NOSE OBSTRUCTION; PARANASAL SINUS; PATHOPHYSIOLOGY; PROGNOSIS; RECURRENT CANCER; RHINORRHEA; ROSETTE FORMATION; SEX DIFFERENCE; UNDIFFERENTIATED CARCINOMA;

EID: 0344012662     PISSN: 09686053     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-6053(03)00068-1     Document Type: Conference Paper

References (133)

1. Hyams V J. Papillomas of the nasal cavity and paranasal sinuses. A clinicopathological study of 315 cases. Ann Otol Rhinol Laryngol 1971; 80: 192-206.
2. Michaels L, Young M. Histogenesis of papillomas of the nose and paranasal sinuses. Arch Pathol Lab Med 1995; 119: 821-826.
3. Michaels L. Benign mucosal tumors of the nose and paranasal sinuses. Semin Diagn Pathol 1996; 13: 113-117.
4. Syrjanen K J. HPV infections in benign and malignant sinonasal lesions. J Clin Pathol 2003; 56: 174-181.
5. Gaffey M J, Frierson H F, Jr., Weiss L M et al. Human papillomavirus and Epstein-Barr virus in sinonasal Schneiderian papillomas. An in situ hybridization and polymerase chain reaction study. Am J Clin Pathol 1996; 106: 475-482.
6. Sarkar F H, Visscher D W, Kintanar E B, Zarbo R J, Crissman J D. Sinonasal Schneiderian papillomas: human papillomavirus typing by polymerase chain reaction. Mod Pathol 1992; 5: 329-332.
7. Macdonald M R, Le K T, Freeman J et al. A majority of inverted sinonasal papillomas carries Epstein-Barr virus genomes. Cancer 1995; 75: 2307-2312.
8. Dunn S T, Clark G D, Cannon T C, Min K W. Survey of sinonasal inverted papillomata for Epstein-Barr virus. Head Neck 1997; 19: 98-106.
9. Vrabec D P. The inverted Schneiderian papilloma: a clinical and pathological study. Laryngoscope 1975; 85: 186-220.
10. Lawson W, Ho B T, Shaari C M, Biller H F. Inverted papilloma: a report of 112 cases. Laryngoscope 1995; 105: 282-288.
11. Suh K W, Facer G W, Devine K D, Weiland L H, Zujko R D. Inverting papilloma of the nose and paranasal sinuses. Laryngoscope 1977; 87: 35-46.
12. Vrabec D P. The inverted Schneiderian papilloma: a 25-year study. Laryngoscope 1994; 104: 582-605.
13. Dictor M, Johnson A. Association of inverted sinonasal papilloma with non-sinonasal head-and-neck carcinoma. Int J Cancer 2000; 85: 811-814.
14. Seshul M J, Eby T L, Crowe D R, Peters G E. Nasal inverted papilloma with involvement of middle ear and mastoid. Arch Otolaryngol Head Neck Surg 1995; 121: 1045-1048.
15. Wenig B M. Schneiderian-type mucosal papillomas of the middle ear and mastoid. Ann Otol Rhinol Laryngol 1996; 105: 226-233.
16. Lasser A, Rothfeld P R, Shapiro R S. Epithelial papilloma and squamous cell carcinoma of the nasal cavity and paranasal sinuses: a clinicopathological study. Cancer 1976; 38: 2503-2510.
17. Snyder R N, Perzin K H. Papillomatosis of nasal cavity and paranasal sinuses (inverted papilloma, squamous papilloma). A clinicopathologic study. Cancer 1972; 30: 668-690.
18. Han J K, Smith T L, Loehrl T, Toohill R J, Smith M M. An evolution in the management of sinonasal inverting papilloma. Laryngoscope 2001; 111: 1395-1400.
19. Ridolfi R L, Lieberman P H, Erlandson R A, Moore O S. Schneiderian papillomas: a clinicopathologic study of 30 cases. Am J Surg Pathol 1977; 1: 43-53.
20. Christensen W N, Smith R R. Schneiderian papillomas: a clinicopathologic study of 67 cases. Hum Pathol 1986; 17: 393-400.
21. Kaufman M R, Brandwein M S, Lawson W. Sinonasal papillomas: clinicopathologic review of 40 patients with inverted and oncocytic Schneiderian papillomas. Laryngoscope 2002; 112: 1372-1377.
22. Nielsen P L, Buchwald C, Nielsen L H, Tos M. Inverted papilloma of the nasal cavity: pathological aspects in a follow-up study. Laryngoscope 1991; 101: 1094-1101.
23. Barnes L, Bedetti C. Oncocytic schneiderian papilloma: a reappraisal of cylindrical cell papilloma of the sinonasal tract. Hum Pathol 1984; 15: 344-351.
24. Calcaterra T C, Thompson J W, Paglia D E. Inverting papillomas of the nose and paranasal sinuses. Laryngoscope 1980; 90: 53-60.
25. Sham C L, Woo J K S, vanHasselt C A. Endoscopic resection of inverted papilloma of the nose and paranasal sinuses. J Laryngol Otol 1998; 112: 758-764.
26. Myers E N, Schramm V L, Jr., Barnes E L, Jr. Management of inverted papilloma of the nose and paranasal sinuses. Laryngoscope 1981; 91: 2071-2084.
27. Kapadia S B, Barnes L, Pelzman K et al. Carcinoma ex oncocytic Schneiderian (cylindrical cell) papilloma. Am J Otolaryngol 1993; 14: 332-338.
28. Walter P, Stebler S, Schaffer P, Vetter J M, Guerbaoui M. Cylindrical epithelioma of nasal cavities and accessory sinuses. Anatomoclinical study of 26 cases. Ann Anat Pathol (Paris) 1976; 21: 463-476.
29. Manivel C, Wick M R, Dehner L P. Transitional (cylindric) cell carcinoma with endodermal sinus tumor-like features of the nasopharynx and paranasal sinuses. Clinicopathologic and immunohistochemical study of two cases. Arch Pathol Lab Med 1986; 110: 198-202.
30. Maitra A, Baskin L B, Lee E L. Malignancies arising in oncocytic Schneiderian papillomas, A report of 2 cases and review of the literature. Arch Pathol Lab Med 2001; 125: 1365-1367.
31. Califano J, Koch W, Sidransky D, Westra W H. Inverted sinonasal papilloma: a molecular genetic appraisal of its putative status as a precursor to squamous cell carcinoma. Am J Pathol 2000; 156: 333-337.
32. Heffner D K, Hyams V J, Hauck K W, Lingeman C. Low-grade adenocarcinoma of the nasal cavity and paranasal sinuses. Cancer 1982; 50: 312-322.
33. Wenig B M, Heffner D K. Respiratory epithelial adenomatoid hamartomas of the sinonasal tract and nasopharynx: a clinicopathologic study of 31 cases. Ann Otol Rhinol Laryngol 1995; 104: 639-645.
34. Cinberg J Z, Solomon M P, Ozbardacki G. Thyroid carcinoma and secondary malignancy of the sinonasal tract. Arch Otolaryngol 1980; 106: 239-241.
35. Kleinsasser O, Schroeder H-G. Adenocarcinomas of the inner nose after exposure to wood dust. Morphological findings and relationships between histopathology and clinical behavior in 79 cases. Arch Otolaryngol 1988; 245: 1-15.
36. Barnes L. Intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Am J Surg Pathol 1986; 10: 192-202.
37. Mills S E, Fechner R E, Cantrell R W. Aggressive sinonasal lesion resembling normal intestinal mucosa. Am J Surg Pathol 1982; 6: 803-809.
38. Franquemont D W, Fechner R E, Mills S E. Histologic classification of sinonasal intestinal-type adenocarcinoma. Am J Surg Pathol 1991; 15: 368-375.
39. Sanchez-Casis G, Devine K D, Welland L H. Nasal adenocarcinomas that closely simulate colonic carcinomas. Cancer 1971; 28: 714-720.
40. Mannetje A, Kogevinas M, Luce D et al. Sinonasal cancer, occupation, and tobacco smoking in European women and men. Am J Ind Med 1999; 36: 101-107.
41. Elwood J M. Wood exposure and smoking: association with cancer of the nasal cavity and paranasal sinuses in British Columbia. Can Med Assoc J 1981; 124: 1573-1577.
42. Perrone F, Oggioni M, Birindelli S et al. TP53, P14ARF, p161NK4 and H-ras gene molecular analysis in intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Int J Cancer 2003; 105: 196-203.
43. Frachi A, Gallo O, Santucci M. Clinical relevance of the histological classification of sinonasal intestinal-type adenocarcinomas. Hum Pathol 1999; 30: 1140-1145.
44. Wenig B M, Hyams V J, Heffner D K. Nasopharyngeal papillary adenocarcinoma. A clinicopathologic study of a low-grade carcinoma. Am J Surg Pathol 1988; 12: 946-953.
45. McKinney C D, Mills S E, Franquemont D W. Sinonasal intestinal-type adenocarcinoma: immunohistochemical profile and comparison with colonic adenocarcinoma. Mod Pathol 1995; 8: 421-425.
46. Bashir A A, Robinson R A, Benda J A, Smith R B. Sinonasal adenocarcinoma: expression of differentiation markers and oncoproteins. Mod Pathol 2002; 15: 215A.
47. Bernstein J M, Montgomery W W, Balogh K. Metastatic tumors to the maxilla, nose, and paranasal sinuses. Laryngoscope 1966; 76: 621-650.
48. Frierson H F, Mills S E, Fechner R E, Taxy J B, Levine P A. Sinonasal undifferentiated carcinoma. Am J Surg Pathol 1986; 10: 771-779.
49. Cerilli L A, Holst V A, Brandwein M S, Stoler M H, Mills S E. Sinonasal undifferentiated carcinoma: immunohistochemical profile and lack of EBV association. Am J Surg Pathol 2001; 25: 156-163.
50. Jeng Y M, Sung M T, Fang C L et al. Sinonasal undifferentiated carcinoma and nasopharyngeal-type undifferentiated carcinoma: two clinically, biologically, and histopathologically distinct entities. Am J Surg Pathol 2002; 26: 371-376.
51. Frierson H F, Ross G W, Stewart F M, Newman S A, Kelly M D. Unusual sinonasal small-cell neoplasms following radiotherapy for bilateral retinoblastomas. Am J Surg Pathol 1989; 13: 947-954.
52. Lopategui J R, Gaffey M J, Frierson H F, Jr. et al. Detection of Epstein-Barr viral RNA in sinonasal undifferentiated carcinoma from Western and Asian patients. Am J Surg Pathol 1994; 18: 391-398.
53. Gallo O, Di Lollo S, Graziani P, Gallina E, Baroni G. Detection of Epstein-Barr virus genome in sinonasal undifferentiated carcinoma by use of in situ hybridization. Otolaryngol Head Neck Surg 1995; 112: 659-664.
54. Deutsch B, Levine P A, Stewart M, Frierson H F, Cantrell R W. Sinonasal undifferentiated carcinoma: a ray of hope. Otolaryngol Head Neck Surg 1993; 108: 697-700.
55. Houston G D, Gillies E. Sinonasal undifferentiated carcinoma: a distinctive clinicopathologic entity. Adv Anat Pathol 1999; 6: 317-323.
56. Mills S E, Fechner R E. 'Undifferentiated' neoplasms of the sinonasal region: differential diagnosis based on clinical, light microscopic, immunohistochemical, and ultrastructural features. Semin Diagn Pathol 1989; 6: 316-328.
57. Berger L, Luc G, Richard D. L'esthésioneuroépithé liome olfactif [in French]. Bull Assoc Fr Etud Cancer 1924; 13: 410-421.
58. Berger L, Coutard H. L'esthésioneurocytome olfactif [in French]. Bull Assoc Fr Etud Cancer 1924; 13: 404-414.
59. Bhattacharyya N, Thornton A F, Joseph M P, Goodman M L, Amrein P C. Successful treatment of esthesioneuroblastoma and neuroendocrine carcinoma with combined chemotherapy and proton radiation. Arch Otolaryngol Head Neck Surg 1997; 123: 34-40.
60. Silva E G, Butler J J, Mackay B, Goepfert H. Neuroblastomas and neuroendocrine carcinomas of the nasal cavity. A proposed new classification. Cancer 1982; 50: 2388-2405.
61. Argani P, Perez-Ordonez B, Xiao H et al. Olfactory neuroblastoma is not related to the Ewing family of tumors. Absence of EWS/FLII gene fusion and MIC2 expression. Am J Surg Pathol 1998; 22: 391-398.
62. Dulguerov P, Calcaterra T C. Esthesioneuroblastoma: the UCLA experience 1970-1990. Laryngoscope 1992; 102: 843-849.
63. Mills S E, Frierson H F. Olfactory neuroblastoma. A clinicopathologic study of 21 cases. Am J Surg Pathol 1985; 9: 317-327.
64. Kadish S, Goodman M, Wang C C. Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer 1976; 37: 1571-1576.
65. Hyams V J, Batsakis J G, Michaels L. Neuroectodermal lesions. In: Tumors of the Upper Respiratory Tract and Ear, 2nd edn. Washington D. C.: Armed Forces Institute of Pathology, 1988; 226-257.
66. Ordoñez N G, Mackay B. Neuroendocrine tumors of the nasal cavity. Pathol Annu 1993; 28: 77-111.
67. Miller D C, Goodman M L, Pilch B Z et al. Mixed olfactory neuroblastoma and carcinoma. A report of two cases. Cancer 1984; 54: 2019-2028.
68. Hirose T, Scheithauer B W, Lopes M B S et al. Olfactory neuroblastoma. An immunohistochemical, ultrastructural, and flow cytometric study. Cancer 1995; 76: 4-19.
69. Frierson H F, Ross G W, Mills S E, Frankfurter A. Olfactory neuroblastoma. Am J Clin Pathol 1990; 94: 547-553.
70. Taxy J B, Bharani N K, Mills S E, Frierson H F, Gould V E. The spectrum of olfactory neural tumors. A light-microscopic immunohistochemical and ultrastructural analysis. Am J Surg Pathol 1986; 10: 687-695.
71. Morita A, Ebersold M J, Olsen K D et al. Esthesioneuroblastoma: prognosis and management. Neurosurgery 1993; 32: 706-714.
72. Ingeholm P, Theilgaard S A, Buchwald C, Hansen H S, Francis D. Esthesioneuroblastoma: a Danish clinicopathological study of 40 consecutive cases. APMIS 2002; 110: 639-645.
73. Chaudhry M R, Akhtar S, Kim D S. Neuroendocrine carcinoma of the ethmoid sinus. Eur Arch Otorhinolaryngol 1994; 251: 461-463.
74. Chang K C, Jin Y T, Chen R M Y, Su I-J. Mixed olfactory neuroblastoma and craniopharyngioma: an unusual pathologic finding. Histopathology 1997; 30: 378-382.
75. Naresh K N, Pai S A. Foci resembling olfactory neuroblastoma and craniopharyngioma are in sinonasal teratocarcinosarcomas. Histopathology 1998; 32: 84.
76. Resto V A, Eisele D W, Forastiere A et al. Esthesioneuroblastoma: the Johns Hopkins experience. Head Neck 2000; 22: 550-558.
77. Appelblatt N H, McClatchey K D. Olfactory neuroblastoma: a retrospective clinicopathologic study. Head Neck Surg 1982; 5: 108-113.
78. Hyams V J, Batsakis J G, Michaels L. Vascular tumors. In: Tumors of the Upper Respiratory Tract and Ear, 2nd edn. Washington D. C.: Armed Forces Institute of Pathology, 1986; 130-145.
79. Giardiello F M, Hamilton S R, Krush A J et al. Nasopharyngeal angiofibroma in patients with familial adenomatous polyposis. Gastroenterology 1993; 105: 1550-1552.
80. Abraham S C, Montgomery E A, Giardiello F M, Wu T T. Frequent beta-catenin mutations in juvenile nasopharyngeal angiofibromas. Am J Pathol 2001; 158: 1073-1078.
81. Guertl B, Beham A, Zechner R, Stammberger H, Hoefler G. Nasopharyngeal angiofibroma: an APC-gene-associated tumor? Hum Pathol 2000; 31: 1411-1413.
82. Hwang H C, Mills S E, Patterson K, Gown A M. Expression of androgen receptors in nasopharyngeal angiofibroma: an immunohistochemical study of 24 cases. Mod Pathol 1998; 11: 1122-1126.
83. Lee D A, Rao B R, Meyer J S, Prioleau P G, Bauer C. Hormonal receptor determination in juvenile nasopharyngeal angiofibromas. Cancer 1980; 46: 547-551.
84. Schiff M, Gonzalez A M, Ong M, Baird A. Juvenile nasopharyngeal angiofibroma contain an angiogenic growth factor: Basic FGF. Laryngoscope 1992; 102: 940-945.
85. Nagai M A, Butugan O, Logullo A, Brentani M M. Expression of growth factors, proto-oncogenes, and p53 in nasopharyngeal angiofibromas. Laryngoscope 1996; 106: 190-195.
86. Johns M E, MacLeod R M, Cantrell R W. Estrogen receptors in nasopharyngeal angiofibromas. Laryngoscope 1980; 90: 628-634.
87. Sternberg S S. Pathology of juvenile nasopharyngeal angiofibroma: a lesion of adolescent males. Cancer 1954; 7: 15-28.
88. Fu Y S, Perzin K H. Non-epithelial tumors of the nasal cavity, paranasal sinuses, and nasopharynx: a clinicopathologic study. I. General features and vascular tumors. Cancer 1974; 33: 1275-1288.
89. Neel H B, Whicker J H, Devine K D, Weiland L H. Juvenile angiofibroma. Review of 120 cases. Am J Surg 1973; 126: 547-556.
90. Beham A, Fletcher C D M, Kainz J, Schmid C, Humer U. Nasopharyngeal angiofibroma: an immunohistochemical study of 32 cases. Virchows Arch A Pathol Anat Histopathol 1993; 423: 281-285.
91. Beham A, Kainz J, Stammberger H R, Aubock L, Beham-Schmid C. Immunohistochemical and electron microscopical characterization of stromal cells in nasopharyngeal angiofibromas. Eur Arch Otorhinolaryngol 1997; 254: 196-199.
92. Taxy J B. Juvenile nasopharyngeal angiofibroma. An ultrastructural study. Cancer 1977; 39: 1044-1054.
93. Goepfert H, Cangi A, Lee Y-Y. Chemotherapy for aggressive juvenile nasopharyngeal angiofibroma. Arch Otolaryngol 1985; 111: 285-289.
94. Spagnolo D V, Papadimitriou J M, Archer M. Postirradiation malignant fibrous histiocytoma arising in juvenile nasopharyngeal angiofibroma and producing alpha-1-antitrypsin. Histopathology 1984; 8: 339-352.
95. Chen K T K, Bauer F W. Sarcomatous transformation of nasopharyngeal angiofibroma. Cancer 1982; 49: 369-371.
96. Hormia M, Koskinen O. Metastasizing nasopharyngeal angiofibroma. A case report. Arch Otolaryngol 1969; 89: 107-110.
97. Compagno J, Hyams V J. Hemangiopericytoma-like intranasal tumors. A clinicopathologic study of 23 cases. Am J Clin Pathol 1976; 66: 672-683.
98. Compagno J. Hemangiopericytoma-like tumors of the nasal cavity: a comparison with hemangiopericytoma of soft tissues. Laryngoscope 1978; 88: 460-469.
99. Tse L L Y, Chan J K C. Sinonasal haemangiopericytoma-like tumor: a sinonasal glomus tumor or haemangiopericytoma. Histopathology 2002; 40: 510-517.
100. Watanabe K, Saito A, Suzuki M, Yamanobe S, Suzuki T. True hemangiopericytoma of the nasal cavity. Immunohistochemical and electron microscopic study of 2 cases and a review of the literature on sinonasal hemangiopericytoma. Arch Pathol Lab Med 2001; 125: 686-690.
101. Smith S R, Som P, Fahmy A et al. A clinicopathological study of sinonasal neuroendocrine carcinoma and sinonasal undifferentiated carcinoma. Laryngoscope 2000; 110: 1617-1622.
102. Purdy Stout A, Murray M R. Hemangiopericytoma. A vascular tumor featuring Zimmermann's pericytes. Ann Surg 1942; 116: 26-33.
103. Beham A, Beham-Schmid C, Regauer S, Aubock L, Stammberger H. Nasopharyngeal angiofibroma: true neoplasm or vascular malformation? Adv Anat Pathol 2000; 7: 36-46.
104. Fletcher C D M. Haemangiopericytoma-a dying breed? Reappraisal of an 'entity'. Curr Diagn Pathol 1994; 1: 19-23.
105. El-Naggar A K, Batsakis J G, Garcia G M, Luna M L, Goepfert H. Sinonasal hemangiopericytomas. A clinicopathologic and DNA content study. Arch Otolaryngol Head Neck Surg 1992; 118: 134-137.
106. Gorenstein A, Facer G W, Weiland L H. Hemangiopericytoma of the nasal cavity. ORL J Otorhinolaryngol Relat Spec 1978; 86: 405-415.
107. Eichhorn J H, Dickersin G R, Bhan A K, Goodman M L. Sinonasal hemangiopericytoma. A reassessment with electron microscopy, immunohistochemistry, and long-term follow-up. Am J Surg Pathol 1990; 14: 856-866.
108. Thompson L D, Miettinen M, Wenig B M. Sinonasal-type haemangiopericytoma: a clinicopathologic and immunophenotypic analysis of 104 cases showing perivascular myoid differentiation. Am J Surg Pathol 2003; 27: 737-749.
109. de Campora E, Calabrese V, Bianchi P M, Camaioni A, Corradini C. Malignant hemangiopericytoma of the nasal cavity. Report of a case and review of the literature. J Laryngol Otol 1983; 97: 963-968.
110. Sugimoto T, Masuda T, Uemura T, Tsuneyoshi M. Hemangiopericytoma-like intranasal tumor: a case report with an immunohistochemical study. Otolaryngol Head Neck Surg 1995; 113: 323-327.
111. Chawla O P, Oswal V H. Haemangiopericytoma of the nose and paranasal sinuses. J Laryngol Otol 1987; 101: 729-737.
112. Torske K R, Thompson L D. Adenoma versus carcinoid tumor of the middle ear: a study of 48 cases and review of the literature. Mod Pathol 2002; 15: 543-555.
113. Riches W G, Johnston W H. Primary adenomatous neoplasms of the middle ear. Light and electron microscopic features of a group distinct from the ceruminomas. Am J Clin Pathol 1982; 77: 153-161.
114. Ketabchi S, Massi D, Franchi A, Vannucchi P, Santucci M. Middle ear adenoma is an amphicrine tumour: why call it adenoma? Ultrastruct Pathol 2001; 25: 73-78.
115. el Naggar A K, Pflatz M, Ordonez N G, Batsakis J G. Tumors of the middle ear and endolymphatic sac. Pathol Annu 1994; 29 (Pt 2): 199-231.
116. Mills S E, Fechner R E. Middle ear adenoma. A cytologically uniform neoplasm displaying a variety of architectural patterns. Am J Surg Pathol 1984; 8: 677-685.
117. Husson M A, Multhaupt H A B, Rosen M R. Primary middle ear carcinoid tumor with immunoelectron microscopic examination. J Surg Pathol 1995; 1: 63-68.
118. Krouse J H, Nadol J B, Goodman M L. Carcinoid tumours of the middle ear. Ann Otol Rhinol Laryngol 1990; 99: 547-552.
119. McNutt M A, Bolen J W. Adenomatous tumor of the middle ear. An ultrastructural and immunocytochemical study. Am J Clin Pathol 1985; 84: 541-547.
120. Stanley M W, Horwitz A A, Levinson R M, Sibley R K. Carcinoid tumors of the middle ear. Am J Clin Pathol 1987; 87: 592-600.
121. Murphy G F, Pilch B Z, Dickersin G R, Goodman M L, Nadol J B. Carcinoid tumor of the middle ear. Am J Clin Pathol 1980; 73: 816-823.
122. Mooney E E, Dodd L G, Oury T D et al. Middle ear carcinoid: an indolent tumor with metastatic potential. Head Neck 1999; 21: 72-77.
123. Wenig B M, Heffner D K. Endolymphatic sac tumors: factor fiction? Adv Anat Pathol 1996; 3: 378-387.
124. Gaffey M J, Mills S E, Boyd J C. Aggressive papillary tumor of middle ear/temporal bone and adnexal papillary cystadenoma. Manifestations of von Hippel-Lindau disease. Am J Surg Pathol 1994; 18: 1254-1260.
125. Manski T J, Heffner D K, Glenn G M et al. Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease. JAMA 1997; 277: 1461-1466.
126. Megerian C A, McKenna M J, Nuss R C et al. Endolymphatic sac tumors: histopathologic confirmation, clinical characterization, and implication in von Hippel-Lindau disease. Laryngoscope 1995; 105: 801-808.
127. Vortmeyer A O, Huang S C, Koch C A et al. Somatic von Hippel-Lindau gene mutations detected in sporadic endolymphatic sac tumors. Cancer Res 2000; 60: 5963-5965.
128. Hamazaki S, Yoshida M, Yao M et al. Mutation of von Hippel-Lindau tumor suppressor gene in a sporadic endolymphatic sac tumor. Hum Pathol 2001; 32: 1272-1276.
129. Vortmeyer A O, Choo D, Pack S D, Oldfield E, Zhuang Z. von Hippel-Lindau disease gene alterations associated with endolymphatic sac tumor. J Natl Cancer Inst 1997; 89: 970-972.
130. Heffner D K. Low-grade adenocarcinoma of probable endolymphatic sac origin. Cancer 1989; 64: 2292-2302.
131. Kempermann G, Neumann P H, Volk B. Endolymphatic sac tumours. Histopathology 1998; 33: 2-10.
132. Mukherji S K, Albernaz V S, Lo W W et al. Papillary endolymphatic sac tumors: CT, MR imaging, and angiographic findings in 20 patients. Radiology 1997; 202: 801-808.
133. Gaffey M J, Mills S E, Fechner R E, Intemann S R, Wick M R. Aggressive papillary middle-ear tumor. Am J Surg Pathol 1988; 12: 790-797.